1-1 of 1
Barbara Hollen, MPH
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Effect of Peroxisome Proliferator–Activated Receptor γ Agonist Treatment on Subclinical Atherosclerosis in Patients With Insulin-Requiring Type 2 Diabetes

Howard N. Hodis, MD, Wendy J. Mack, PHD, Ling Zheng, PHD, Yanjie Li, MD, Mina Torres, MS, Diego Sevilla, PA, Yolanda Stewart, BS, Barbara Hollen, MPH, Karla Garcia, BA, Petar Alaupovic, PHD, Thomas A. Buchanan, MD
Journal: Diabetes Care
Diabetes Care 2006;29(7):1545–1553
https://doi.org/10.2337/dc05-2462
Published: 01 July 2006
View article titled, Effect of Peroxisome Proliferator–Activated Receptor γ Agonist Treatment on Subclinical Atherosclerosis in Patients With Insulin-Requiring Type 2 Diabetes
Open the PDF for Effect of Peroxisome Proliferator–Activated Receptor γ Agonist Treatment on Subclinical Atherosclerosis in Patients With Insulin-Requiring Type 2 Diabetes in another window